Completed PHASE4 INTERVENTIONAL 2-arm NCT00987610

Guidewire for Chronic Total Occlusion (G-FORCE)

Multicenter Prospective Randomized Study of First-choice Guidewires in Percutaneous Coronary Intervention for Chronic Total Occlusion

Sponsor: Abbott Medical Devices

Conditions Coronary Occlusion

Interventions Percutaneous coronary intervention (PCI)

Updated 8 times since 2017 Last updated: May 1, 2015 Started: Oct 31, 2009 Primary completion: Dec 31, 2014 Completion: Dec 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Coronary Occlusion, this trial is completed. The trial is conducted by Abbott Medical Devices and has accumulated 8 data snapshots since 2009. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Oct 2021 — Jul 2024 [monthly]

Completed PHASE4
Jan 2021 — Oct 2021 [monthly]

Completed PHASE4

▶ Show 3 earlier versions

Dec 2018 — Jan 2021 [monthly]

Completed PHASE4
Jun 2018 — Dec 2018 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Oct 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Abbott Medical Devices
Asahi Intech
Japan Lifeline
Kaneka Medical America LLC
Terumo Medical Corporation
Tokai University

Data source: Tokai University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Amagasaki, Japan , Aomori, Japan , Hiroshima, Japan , Isehara, Japan , Kamakura, Japan , Kashiwa, Japan , Kitakyushu, Japan , Kobe, Japan , Kurashiki, Japan , Kurume, Japan and 12 more locations